Clinical characteristics and virological responses to pegylated interferon plus ribavirin combination therapy in the hepatitis B and C virus coinfected patients
机构：[1]The First Affiliated Hospital of Kunming MedicalUniversity, Kunming, China昆明医科大学附属第一医院[2]The Third People’s Hospital of Kunming, Kunming,China[3]Faculty of Medicine, Prince of Songkla University,Hat Yai, Songkhla, Thailand[4]The First People’s Hospital of Kunming, Kunming,Kunming, China[5]Haiyuan Medical College, Kunming MedicalUniversity, Kunming, China[6]The Yunnan General Hospital of The ChinesePeople’s Armed Police Forces, Kunming, China[7]The Third People’s Hospital of Yunnan Province,Kunming, China
第一作者机构：[1]The First Affiliated Hospital of Kunming MedicalUniversity, Kunming, China
推荐引用方式(GB/T 7714)：
J. You,Y.Z. Yan,L. Zhuang,et al.Clinical characteristics and virological responses to pegylated interferon plus ribavirin combination therapy in the hepatitis B and C virus coinfected patients[J].INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES.2014,21:320-+.doi:10.1016/j.ijid.2014.03.1083.
APA：
J. You,Y.Z. Yan,L. Zhuang,H.Y. Chen,X.Feng...&B.Z.Tang.(2014).Clinical characteristics and virological responses to pegylated interferon plus ribavirin combination therapy in the hepatitis B and C virus coinfected patients.INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES,21,
MLA：
J. You,et al."Clinical characteristics and virological responses to pegylated interferon plus ribavirin combination therapy in the hepatitis B and C virus coinfected patients".INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES 21.(2014):320-+
医学